Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib was effective for severe, treatment-resistant hair loss without side effects.

The topical treatment with caffeine and Procapil 3% improved male pattern hair loss and was well tolerated after 12 weeks.

New psoriasis treatments are effective but come with side effects and risks.

Cold Plasma shows promise for healing wounds by killing bacteria and helping tissue grow.

KRTAP2-3 could help predict cancer recurrence by identifying specific cancer cells.

Combining PRP with Procapil is more effective for hair loss treatment than PRP alone.

c-Kit is important for heart regeneration and cancer development.

Tofacitinib may effectively treat skin symptoms in difficult cases of dermatomyositis.

Semecarpus anacardium leaf extracts may offer safe, effective cancer treatment alternatives.

2007 research improved understanding of prostate cancer risk, diagnosis, and treatment, but also showed the need for personalized treatment and further study on certain therapies' risks.

Blocking mTORC1 reduces skin tumor growth in mice.

A 15-year-old boy's severe scalp condition improved significantly with adalimumab and baricitinib treatment.

Ion sequential therapy improves heart function after a heart attack.

Topical tacalcitol can treat psoriasis by acting directly on skin cells.

Overexpression of PKCepsilon leads to increased TNFalpha, promoting metastatic squamous cell carcinoma in mice.

Using tazarotene with GliSODin improves facial skin more than tazarotene alone.

New drugs and therapies targeting specific pathways show promise in treating advanced prostate cancer.

Point of Care in radiology speeds up diagnosis and treatment by performing tests where the patient is.

The patch delivers more drugs through the skin effectively.

Risankizumab effectively treats and maintains skin clearance in moderate-to-severe psoriasis.

The new technique PÂTÉ improved the amount of scalp tissue removed in surgeries.

Tofacitinib helps hair regrow in some kids with severe alopecia areata, but more research is needed on long-term effects.

Clobetasol propionate 0.05% ointment is more effective than tacrolimus 0.1% ointment for treating alopecia areata.

Two patients treated with TAC for mouth fibrosis improved but developed Cushing's Syndrome symptoms.

Sacituzumab govitecan improves quality of life and symptoms in breast cancer patients, except for causing more diarrhea.

SARMs may be an effective treatment for a certain type of breast cancer by blocking cancer growth and spread.

CuATSM speeds up wound healing and reduces scarring.

Tofacitinib shows promise for treating severe hair loss in adults and teens, with many experiencing regrowth, but hair loss returns when treatment stops.

AD198 is more effective than doxorubicin in stopping certain dog cancer cells.

The trial on testosterone replacement therapy in older men faced concerns due to prostate cancer risk.